Kala Pharmaceuticals Competitors, Revenue and Alternatives
Navigation
Overview
City Ranking
Industry Ranking
State Ranking
Growjo 10k Ranking
Estimated Revenue & Financials
- Kala Pharmaceuticals's estimated annual revenue is currently $10.7M per year.
- Kala Pharmaceuticals received $110.0M in venture funding in October 2018.
- Kala Pharmaceuticals's estimated revenue per employee is $70,086
- Kala Pharmaceuticals's total funding is $121.2M.
Employee Data
- Kala Pharmaceuticals has 152 Employees.
- Kala Pharmaceuticals grew their employee count by 1% last year.
- Kala Pharmaceuticals currently has 45 job openings.
Kala Pharmaceuticals Competitors
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
| N/A | 445 | N/A | N/A | |
| N/A | 411 | N/A | N/A | |
| $30.3M | 385 | 50% | N/A | |
| $5.4M | 27 | N/A | N/A | |
| $17.3M | 86 | 48% | N/A | |
| $10.3M | 51 | 50% | N/A | |
| $51.9M | 258 | 15% | N/A | |
| N/A | 453 | N/A | N/A | |
| $546.3M | 2718 | N/A | N/A | |
| N/A | 179 | N/A | N/A |
What Is Kala Pharmaceuticals?
Kala Pharmaceuticals, Inc. (Kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. For more information, please visit Kala's website at www.kalarx.com.
keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Security,Wind Power152
Number of Employees
$10.7M
Revenue (est)
45
Current Jobs
1%
Employee Growth %
$121.2M
Total Funding
N/A
Valuation
N/A
Accelerator
B2B
Type
Executive Contacts
| Name | Title | |
|---|---|---|
| Hongming Chen | Chief Scientific Officer | Email Available |
| Kim Brazzell | Chief Medical Officer | |
| Evan Rosenberg | Accounting Manager | Email Available |
| Todd Bazemore | Chief Operating Officer | |
| Mary Reumuth | Chief Financial Officer | |
| Christine Fiumara | Territory Sales Manager | Email Available |
| Seamus Gillespie | Director Of Finance | Email Available |
| Brett Obrovac | Territory Sales Manager | Email Available |
| Lindy Bolling | Territory Sales Manager - Michigan | Email Available |
| Briana Foster | Director, Commercial Learning & Development | Email Available |
Kala Pharmaceuticals News
Kala Pharmaceuticals, Inc. (KALA), today announced that the Company granted non-statutory stock options to new employees as inducement ...
Kala Pharmaceuticals, Inc. (KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its ...
Kala Pharmaceuticals, Inc. (NASDAQ:KALA) is among the top stocks that may remain in focus today as the company shares are trading 3.46% ...
Kala Pharmaceuticals Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2012-03-15 | $6.2M | Undisclosed | Lux Capital, Polaris Venture Partners | Article |
| 2013-03-01 | $11.5M | A | Crown Venture Fund LLC | Article |
| 2014-04-24 | $22.5M | B | Ysios Capital | Article |
| 2016-04-14 | $68.0M | C | Longitude Capital | Article |
| 2018-10-03 | $110.0M | Undisclosed | Athyrium Capital Management | Article |
Kala Pharmaceuticals Executive Hires
| Date | Name | Title | Reference |
|---|---|---|---|
| 2012-07-13 | Guillaume Pfefer | CEO/President | Article |
| 2013-03-01 | Kim Brazzell | Chief Medical Officer | Article |
| 2013-05-29 | Charles McDermott | EVP Business Development | Article |
| 2014-01-07 | Howard B. Rosen | Chairman | Article |
| 2015-05-15 | Mark Iwicki | Executive Chairman | Article |
| 2017-11-14 | Todd Bazemore | Chief Operating Officer | Article |
| 2018-04-04 | Eric Trachtenberg | General Counsel and Corporate Secretary. | Article |
| 2018-10-26 | Steven Zhang | Vice President of Medical Affairs | Article |